Literature DB >> 11191354

Changing concepts of the pulmonary plexiform lesion.

A P Fishman1.   

Abstract

The plexiform lesion is the hallmark of plexogenic pulmonary arteriopathy, which accompanies severe primary pulmonary hypertension. Over the years, a wide variety of hypotheses have been offered to explain the pathogenesis of these glomoid structures. Most recently, the new techniques and concepts of molecular biology have been applied to the study of the plexiform lesion and have indicated that they are composed of phenotypically abnormal endothelial cells with different pathogenic origins in primary and secondary pulmonary hypertension. The new approaches and concepts have suggested new vistas for exploration.

Entities:  

Mesh:

Year:  2000        PMID: 11191354

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  13 in total

1.  Aicardi goutières syndrome is associated with pulmonary hypertension.

Authors:  Laura A Adang; David B Frank; Ahmed Gilani; Asako Takanohashi; Nicole Ulrick; Abigail Collins; Zachary Cross; Csaba Galambos; Guy Helman; Usama Kanaan; Stephanie Keller; Dawn Simon; Omar Sherbini; Brian D Hanna; Adeline L Vanderver
Journal:  Mol Genet Metab       Date:  2018-09-07       Impact factor: 4.797

2.  Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment.

Authors:  Danny Jonigk; Heiko Golpon; Clemens L Bockmeyer; Lavinia Maegel; Marius M Hoeper; Jens Gottlieb; Nils Nickel; Kais Hussein; Ulrich Maus; Ulrich Lehmann; Sabina Janciauskiene; Tobias Welte; Axel Haverich; Johanna Rische; Hans Kreipe; Florian Laenger
Journal:  Am J Pathol       Date:  2011-05-11       Impact factor: 4.307

3.  Aneurysm-type plexiform lesions form in supernumerary arteries in pulmonary arterial hypertension: potential therapeutic implications.

Authors:  Kaori Oshima; Edward S Crockett; Sachindra R Joshi; Jared M McLendon; Yuri Matsumoto; Ivan F McMurtry; Kohtaro Abe; Masahiko Oka
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-02       Impact factor: 5.464

Review 4.  Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Authors:  Salma Siddique; Jessie Risse; Guillaume Canaud; Stéphane Zuily
Journal:  Curr Rheumatol Rep       Date:  2017-09-04       Impact factor: 4.592

Review 5.  Pulmonary hypertension in antiphospholipid syndrome.

Authors:  Stéphane Zuily; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

Review 6.  Pulmonary artery aneurysms: four case reports and literature review.

Authors:  Panagiotis Theodoropoulos; Bulat A Ziganshin; Maryann Tranquilli; John A Elefteriades
Journal:  Int J Angiol       Date:  2013-09

7.  Angiogenic biomarkers in children with congenital heart disease: possible implications.

Authors:  Nagla T El-Melegy; Nagwa A Mohamed
Journal:  Ital J Pediatr       Date:  2010-04-20       Impact factor: 2.638

8.  Endothelial hyperpermeability in severe pulmonary arterial hypertension: role of store-operated calcium entry.

Authors:  Chun Zhou; Mary I Townsley; Mikhail Alexeyev; Norbert F Voelkel; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-15       Impact factor: 5.464

9.  Upregulated genes in sporadic, idiopathic pulmonary arterial hypertension.

Authors:  Alasdair J Edgar; Matilde R Chacón; Anne E Bishop; Magdi H Yacoub; Julia M Polak
Journal:  Respir Res       Date:  2006-01-03

10.  Abnormal pulmonary perfusion heterogeneity in patients with Fontan circulation and pulmonary arterial hypertension.

Authors:  Susan R Hopkins; Rui C Sá; G Kim Prisk; Ann R Elliott; Nick H Kim; Beni J Pazar; Beth F Printz; Howaida G El-Said; Christopher K Davis; Rebecca J Theilmann
Journal:  J Physiol       Date:  2020-10-27       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.